FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions
Designation underscores potential of chemically induced, off-the-shelf cell therapy to address high…
Harvest Global Investments Announces New CEO and Executive Appointments, Deepening Synergy with Parent Company Harvest Fund to Pioneer New Horizons in Cross-Border Investment
HONG KONG, Jan. 19, 2026 /PRNewswire/ — Harvest Global Investments Limited ("HGI"), the…